Log In
Print this Print this

Amphetamine XR oral suspension

  Manage Alerts
Collapse Summary General Information
Company Neos Therapeutics Inc.
DescriptionOral suspension extended-release amphetamine polistirex using Neos' dynamic time release suspension (DTRS) technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today